Skip to main content Help with accessibility Skip to main navigation

RITUXIMAB (Truxima®▼, Rixathon®▼) for immune (idiopathic) thrombocytopenic purpura

CCG Approval Status:

Date Added: 26 - Jun - 2019
Red

RITUXIMAB (Truxima®▼, Rixathon®▼)The Pan Mersey Area Prescribing Committee recommends the prescribing of rituximab by specialists only, for immune (idiopathic) thrombocytopenic purpura before romiplostin and eltrombopag.